• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌易感性中的DNA甲基化

DNA Methylation in Ovarian Cancer Susceptibility.

作者信息

Reid Brett M, Fridley Brooke L

机构信息

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

出版信息

Cancers (Basel). 2020 Dec 31;13(1):108. doi: 10.3390/cancers13010108.

DOI:10.3390/cancers13010108
PMID:33396385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7795210/
Abstract

Epigenetic alterations are somatically acquired over the lifetime and during neoplastic transformation but may also be inherited as widespread 'constitutional' alterations in normal tissues that can cause cancer predisposition. Epithelial ovarian cancer (EOC) has an established genetic susceptibility and mounting epidemiological evidence demonstrates that DNA methylation (DNAm) intermediates as well as independently contributes to risk. Targeted studies of known EOC susceptibility genes (CSGs) indicate rare, constitutional promoter methylation increases familial and sporadic EOC risk. Blood-based epigenome-wide association studies (EWAS) for EOC have detected a total of 2846 differentially methylated probes (DMPs) with 71 genes replicated across studies despite significant heterogeneity. While EWAS detect both symptomatic and etiologic DMPs, adjustments and analytic techniques may enrich risk associations, as evidenced by the detection of dysregulated methylation of -a known CSG identified by genome-wide associations studies (GWAS). Integrative genetic-epigenetic approaches have mapped methylation quantitative trait loci (meQTL) to EOC risk, revealing DNAm variations that are associated with nine GWAS loci and, further, one novel risk locus. Increasing efforts to mapping epigenome variation across populations and cell types will be key to decoding both the genomic and epigenomic causal pathways to EOC.

摘要

表观遗传改变是在个体一生中以及肿瘤转化过程中体细胞获得的,但也可能作为正常组织中广泛存在的“构成性”改变而遗传,这些改变可导致癌症易感性。上皮性卵巢癌(EOC)具有明确的遗传易感性,越来越多的流行病学证据表明,DNA甲基化(DNAm)中间体以及独立因素均对风险有影响。对已知的EOC易感基因(CSG)进行的靶向研究表明,罕见的、构成性的启动子甲基化会增加家族性和散发性EOC风险。针对EOC的基于血液的全表观基因组关联研究(EWAS)共检测到2846个差异甲基化探针(DMP),尽管存在显著异质性,但有71个基因在各研究中得到重复。虽然EWAS可检测有症状和病因性的DMP,但调整和分析技术可能会丰富风险关联,如对通过全基因组关联研究(GWAS)确定的一个已知CSG的甲基化失调的检测所证明的那样。综合遗传 - 表观遗传方法已将甲基化数量性状位点(meQTL)映射到EOC风险,揭示了与9个GWAS位点相关的DNAm变异,此外还有一个新的风险位点。加大努力绘制不同人群和细胞类型的表观基因组变异图谱,将是解码EOC基因组和表观基因组因果途径的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/7795210/585db170875d/cancers-13-00108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/7795210/585db170875d/cancers-13-00108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/7795210/585db170875d/cancers-13-00108-g001.jpg

相似文献

1
DNA Methylation in Ovarian Cancer Susceptibility.卵巢癌易感性中的DNA甲基化
Cancers (Basel). 2020 Dec 31;13(1):108. doi: 10.3390/cancers13010108.
2
Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.针对全血细胞计数进行校正后,对基于血液的区域DNA甲基化进行全基因组研究,结果表明BNC2基因与卵巢癌有关。
Genet Epidemiol. 2014 Jul;38(5):457-66. doi: 10.1002/gepi.21815. Epub 2014 May 22.
3
Genome- and epigenome-wide association studies identify susceptibility of CpG sites and regions for metabolic syndrome in a Korean population.全基因组和表观基因组关联研究鉴定了韩国人群代谢综合征中 CpG 位点和区域的易感性。
Clin Epigenetics. 2024 Apr 29;16(1):60. doi: 10.1186/s13148-024-01671-5.
4
Genetic Regulation of DNA Methylation Yields Novel Discoveries in GWAS of Colorectal Cancer.遗传调控 DNA 甲基化在结直肠癌 GWAS 中产生新发现。
Cancer Epidemiol Biomarkers Prev. 2022 May 4;31(5):1068-1076. doi: 10.1158/1055-9965.EPI-21-0724.
5
Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers.全基因组 DNA 甲基化组分析鉴定出与卵巢癌生存和耐药相关的甲基化特征。
Clin Epigenetics. 2021 Jul 22;13(1):142. doi: 10.1186/s13148-021-01130-5.
6
An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation.精神分裂症的综合遗传-表观遗传分析:遗传关联与DNA甲基化差异共定位的证据
Genome Biol. 2016 Aug 30;17(1):176. doi: 10.1186/s13059-016-1041-x.
7
Epigenome-wide association study of plasma lipids in West Africans: the RODAM study.西非人群血浆脂质的全基因组关联研究:RODAM 研究。
EBioMedicine. 2023 Mar;89:104469. doi: 10.1016/j.ebiom.2023.104469. Epub 2023 Feb 13.
8
Identification of novel meQTLs strongly associated with rheumatoid arthritis by large-scale epigenome-wide analysis.通过大规模的全基因组表观遗传分析,确定与类风湿关节炎强烈相关的新型 meQTLs。
FEBS Open Bio. 2022 Dec;12(12):2227-2235. doi: 10.1002/2211-5463.13517. Epub 2022 Nov 19.
9
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.整合基因组分析确定了介导上皮性卵巢癌遗传风险的表观遗传标记。
BMC Med Genomics. 2014 Jan 30;7:8. doi: 10.1186/1755-8794-7-8.
10
An epigenome-wide association study of posttraumatic stress disorder in US veterans implicates several new DNA methylation loci.一项针对美国退伍军人创伤后应激障碍的全基因组关联研究表明,有几个新的 DNA 甲基化位点与创伤后应激障碍有关。
Clin Epigenetics. 2020 Mar 14;12(1):46. doi: 10.1186/s13148-020-0820-0.

引用本文的文献

1
Genetic Polymorphisms in Base Excision Repair (BER) and Nucleotide Excision Repair (NER) Pathways as Potential Biomarkers for Gynecological Cancers: A Comprehensive Literature Review.碱基切除修复(BER)和核苷酸切除修复(NER)途径中的基因多态性作为妇科癌症的潜在生物标志物:一项综合文献综述
Cancers (Basel). 2025 Jun 27;17(13):2170. doi: 10.3390/cancers17132170.
2
Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.没食子酸表没食子儿茶素酯治疗妇科良恶性疾病的研究进展——关注表观遗传学机制。
Nutrients. 2024 Feb 17;16(4):559. doi: 10.3390/nu16040559.
3
Comprehensive Analysis of DNA Methyltransferases Expression in Primary and Relapsed Ovarian Carcinoma.

本文引用的文献

1
New tools to prevent cancer growth and spread: a 'Clever' approach.新工具可预防癌症生长和扩散:一种“巧妙”的方法。
Br J Cancer. 2020 Aug;123(4):501-509. doi: 10.1038/s41416-020-0953-0. Epub 2020 Jun 29.
2
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes.综合基因组分析方法鉴定与早期卵巢癌组织类型相关的分子特征。
Sci Rep. 2020 May 14;10(1):7946. doi: 10.1038/s41598-020-64794-8.
3
Analysis of and Promoter Methylation in Italian Families at High-Risk of Breast and Ovarian Cancer.
原发性和复发性卵巢癌中DNA甲基转移酶表达的综合分析
Cancers (Basel). 2023 Oct 11;15(20):4950. doi: 10.3390/cancers15204950.
4
Homologous Recombination Deficiency Score Determined by Genomic Instability in a Romanian Cohort.罗马尼亚队列中由基因组不稳定性确定的同源重组缺陷评分
Diagnostics (Basel). 2023 May 29;13(11):1896. doi: 10.3390/diagnostics13111896.
5
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.甲基化特征与卵巢高级别浆液性癌的免疫抑制活动有关。
Cancer Epidemiol Biomarkers Prev. 2023 Apr 3;32(4):542-549. doi: 10.1158/1055-9965.EPI-22-0941.
6
Integration of Transcriptome and Epigenome to Identify and Develop Prognostic Markers for Ovarian Cancer.整合转录组和表观基因组以鉴定和开发卵巢癌的预后标志物。
J Oncol. 2022 Aug 30;2022:3744466. doi: 10.1155/2022/3744466. eCollection 2022.
7
A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer.一种潜在指标ARRDC2对评估卵巢癌预后和免疫微环境具有可行性。
Front Genet. 2022 May 18;13:815082. doi: 10.3389/fgene.2022.815082. eCollection 2022.
8
The Study of Cancer Susceptibility Genes.癌症易感基因的研究
Cancers (Basel). 2021 May 8;13(9):2258. doi: 10.3390/cancers13092258.
意大利乳腺癌和卵巢癌高危家族中[具体基因]及启动子甲基化分析
Cancers (Basel). 2020 Apr 8;12(4):910. doi: 10.3390/cancers12040910.
4
Inflammasome expression is higher in ovarian tumors than in normal ovary.在卵巢肿瘤中的炎症小体表达高于正常卵巢。
PLoS One. 2020 Jan 10;15(1):e0227081. doi: 10.1371/journal.pone.0227081. eCollection 2020.
5
CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K/Akt/mTOR pathway.CADM1 通过潜在调节 PI3K/Akt/mTOR 通路抑制卵巢癌细胞增殖和迁移。
Biomed Pharmacother. 2020 Mar;123:109717. doi: 10.1016/j.biopha.2019.109717. Epub 2019 Dec 25.
6
Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.利用综合生物信息学分析鉴定肺鳞状细胞癌中的关键基因并评估临床结局
Oncol Lett. 2019 Dec;18(6):5859-5870. doi: 10.3892/ol.2019.10933. Epub 2019 Sep 30.
7
Genome-wide identification of DNA methylation QTLs in whole blood highlights pathways for cardiovascular disease.全血细胞中 DNA 甲基化 QTL 的全基因组鉴定突出了心血管疾病的相关途径。
Nat Commun. 2019 Sep 19;10(1):4267. doi: 10.1038/s41467-019-12228-z.
8
The diverse roles of DNA methylation in mammalian development and disease.DNA 甲基化在哺乳动物发育和疾病中的多种作用。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):590-607. doi: 10.1038/s41580-019-0159-6. Epub 2019 Aug 9.
9
Constitutional Mosaic Epimutations - a hidden cause of cancer?遗传性镶嵌性表观突变——癌症的一个潜在病因?
Cell Stress. 2019 Mar 22;3(4):118-135. doi: 10.15698/cst2019.04.183.
10
Intergenerational epigenetic inheritance of cancer susceptibility in mammals.哺乳动物中癌症易感性的跨代表观遗传遗传。
Elife. 2019 Apr 9;8:e39380. doi: 10.7554/eLife.39380.